28 November 2018 in PLOS ONE
TGthe ALLIANCE-study group
+7
Human rhinovirus infection (HRVI) plays an important role in asthma exacerbations and is thought to be involved in asthma development during early childhood. We hypothesized that HRVI causes differential DNA methylation and subsequently differential mRNA expression in epithelial cells of children with asthma. Primary nasal epithelial cells from children with (n = 10) and without (n = 10) asthma were cultivated up to passage two and infected with Rhinovirus-16 (RV-16). HRVI-induced genome-wide differences of DNA methylation in asthmatics (vs. controls) and resulting mRNA expression were analyzed by the HumanMethylation450 BeadChip Kit (Illumina) and RNA sequencing. These results were further verified by pyrosequencing and quantitative PCR, respectively. 471 CpGs belonging to 268 genes were identified to have HRVI-induced asthma-specifically modified DNA methylation and mRNA expression. A minimum-change criteria was applied to restrict assessment of genes with changes in DNA methylation and mRNA expression of at least 3% and least 0.1 reads/kb per million mapped reads, respectively. Using this approach we identified 16 CpGs, including HLA-B-associated transcript 3 (BAT3) and Neuraminidase 1 (NEU1), involved in host immune response against HRVI. HRVI in nasal epithelial cells leads to specific modifications of DNA methylation with altered mRNA expression in children with asthma. The HRVI-induced alterations in DNA methylation occurred in genes involved in the host immune response against viral infections and asthma pathogenesis. The findings of our pilot study may partially explain how HRVI contribute to the persistence and progression of asthma, and aid to identify possible new therapeutic targets. The promising findings of this pilot study would benefit from replication in a larger cohort.
5 September 2021 in European Respiratory Journal
Background: Several environmental exposures like rhinovirus infections alter DNA methylation in airway cells which presents a mechanism through which risk to airflow inflammation and obstruction is posed. Collagen type 4 alpha 3 (COL4A3) is a basal membrane constituent and has anti-angiogenic and anti-inflammatory properties in asthma. COL4A3 is reduced in asthmatic airways. However, the mechanism underlying COL4A3 reduction has remained elusive to date. Objective: To investigate whether ZNF263 binding and an intronic methylation regulate COL4A3 expression in asthmatic epithelium. Methods: RNA and DNA from bronchial biopsies (BB) of 76 asthmatics, 83 controls and from BEAS-2Bs infected with rhinovirus-16 (RV-16) were isolated (AllPrep DNA/RNA kit, Qiagen) and subjected to RNA-sequencing (HiSeq 2500 system, Illumina) and DNA methylation (450k BeadChip, Illumina) analysis. Zinc finger protein (ZNF) 263 binding was assessed by quantitative chromatin immunoprecipitation. Methylation was quantified by pyrosequencing (PyroMark Q24 system, Qiagen). ZNF263 was silenced (ZNF263 On-Target siRNA, Dharmacon technologies) and COL4A3 expression was measured by qPCR. Results: In asthmatic BBs, COL4A3 expression was significantly decreased (pCOL4A3 expression (-60%, pCOL4A3 expression (-40%, p. Conclusion: Our data suggests an epigenetic modification at cg11797365 interrupts ZNF263 binding which may contribute to the COL4A3 expression deficit in asthmatic airways.